PAVmed (PAVM) Expected to Announce Quarterly Earnings on Tuesday

PAVmed (NASDAQ:PAVM) is anticipated to post its quarterly earnings results before the market opens on Tuesday, March 25th. Analysts expect PAVmed to post earnings of ($0.40) per share and revenue of $0.02 million for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.

PAVmed Stock Up 5.6 %

Shares of PAVM opened at $0.81 on Friday. PAVmed has a 52 week low of $0.57 and a 52 week high of $2.84. The company has a market capitalization of $8.97 million, a price-to-earnings ratio of -0.19 and a beta of 1.19. The stock’s 50-day moving average price is $0.69 and its 200-day moving average price is $0.92.

Analysts Set New Price Targets

Separately, Ascendiant Capital Markets lowered their price target on PAVmed from $21.00 to $19.00 and set a “buy” rating on the stock in a research report on Monday, December 9th.

About PAVmed

PAVmed Inc focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck.